viewArcadia Biosciences Inc

Arcadia Biosciences nears commercialization of its new wheat-based products

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Raj Ketkar and CFO Matt Plavan tells Proactive Investors the health and nutrition company is getting very close to commercialization of its technology to produce new, healthier wheat products with consumer packaged-goods companies using both enriched and whole wheat RS wheat flour.

Ketkar says the California-based company's products, including a form of resistant starch, manage obesity and diabetes since the body takes longer to break down starch in the wheat, allowing consumers to feel more full. Plavan adds the company is well funded, recently closing on $13.83mln worth of capital.

Quick facts: Arcadia Biosciences Inc

Price: 5.06 USD

Market: NASDAQ
Market Cap: $43.6 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Arcadia Biosciences Inc named herein, including the promotion by the Company of Arcadia Biosciences Inc in any Content on the Site, the Company...



Full interview: Arcadia Biosciences makes major progress on its hemp venture...

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Raj Ketkar tells Proactive the California-based company expects to “significantly scale revenues in 2020” as it reported financial and business results for the second quarter and first half of 2019. Ketkar says the agricultural innovation company made...

on 08/16/2019

2 min read